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Simplified description and interpretation of
pathological thermography signs in malignant
breast lesions
Abstract
Background and Purpose: Breast cancer is the leading cause of death
among women aged 20–59 years in developed countries, with similar mor-
tality trends, observed among women in Croatia. Breast cancer detection
usually relies on mammography, ultrasound (US) and magnetic resonance
imaging (MRI), however, thermography is a noninvasive, reliable and ap-
plicable diagnostic procedure for early detection of breast disease that has at-
tracted interest in this field. The aim of this study was to establish the fre-
quency and characteristics of pathological thermographic signs in female
patients, who were operated on malignant breast lesions. In addition, the
authors offered a simplified description and interpretation of pathological
thermographic signs, based on published literature.
Matherial and Methods: The seventy four female patients with histo-
pathologically confirmed breast cancer were included in the study. In all
patients breast cancer was diagnosed using standard protocol which have in-
cluded clinical examination, mammography, ultrasound and for selected
patients MRI and/or fine needle aspiration (FNA). Thermographic imag-
ing has been conducted 1 to 14 days before scheduled surgical procedures.
Results: Mean tumor size positively correlated with number of patho-
logical thermographic signs (IR 3 vs. IR 5, p < 0.05). Mean number of
pathological thermographic signs per patient was 3.5±1, 72 (range 1 to 8).
The most frequently noted singular signs were heat in area of finding and
vascular signs, as well.
Conclusion: The simplified description could offer a suitable clinical
tool for standardization of pathological thermography signs in malignant
breast lesions, taking into account the learning curve of medical teams in-
volved and ethical aspects, as well.
INTRODUCTION
Globally, cardiovascular disease is the leading cause of death inwomen. Cancers of the breast, lung and colon are among the top
ten causes of death of older women globally. Worldwide, breast cancer
comprises 22.9% of all cancers (excluding non-melanoma skin cancers)
in women. In 2008, breast cancer caused 458,503 deaths worldwide
(13.7%) of cancer deaths in women. Breast cancer is the leading cancer
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Mortality trends in Republic Croatia are the similar.
Leading cause of death among women is cardiovascular
disease (14 881) in 2009. Breast cancer is the most preva-
lent women’s cancer with 2473 new cases in 2008. and
cause about 1000 deaths in 2010. Both, incidence and
mortality trend are increasing (2).
High prevalence of the disease and identification of
biological factors important for its development and pro-
gression (3) justify the high public interest for new find-
ings and recommendations in this field that would im-
prove its prognosis (4, 5). Advancements in molecular
and genetic mechanisms of breast cancer have lead to re-
alization that the breast cancer is heterogeneous disease
whose prognosis depends on both biological and clinical
parameters. Inclusion of biological tumor markers to the
earliest decision-making requires advancements in clini-
cal diagnostic protocols and could mark a new treatment
based on individual approach to each patient (6).
Thermography is a non invasive, reliable and applica-
ble diagnostic procedure for early detection of breast dis-
ease that has attracted interest in this field (7, 8, 9, 10).
Thermography detects the heat emitted by the body of
the patient and with the use of sensitive thermal cameras
is capable of depicting temperature changes of 0.07 °C. It
is comfortable since it is not associated with the use of
ionizing radiation or mechanical pressure on the breast
tissue that is required for mammography imaging. The
method itself is biologically inert and could, therefore, be
used without limitations for continuous monitoring of
changes without detrimental effects for health of the
women. Change of the skin surface temperature that is
being measured results from various chemical mediators
that create suitable environment for tumor growth and
propagation. Therefore, unlike other methods that de-
tect morphological changes, thermography is much mo-
re suitable to follow the tumor development (11, 12). It is
striking that thermography can detect biological signs of
breast cancer up to 10 years before the appearance of clin-
ically significant disease (»too early, too right«) (8), and
has shown its promise in several studies (13, 14, 15,16).
Medical thermography was first applied in 1957. when a
surgeon, Dr. R. Lawson discovered that his breast cancer
patients had higher skin temperature over the cancer
area. Since the 1970’s thermography has been used in
many areas of medicine. Early problems such as low de-
tector sensitivity, but most significantly, poor training
thermography technicians was the source of error in
thermography and retarded the acceptance of this tech-
nique until 1990. Since that time, thermographic equip-
ment has evolved significantly. Modern thermal imaging
systems comprise technically advanced thermal cameras
coupled to computers with sophisticated software solu-
tions. The recorded images are now of good quality and
may be further processed to obtain reliable information.
Contemporary thermal imaging must be performed ac-
cording to certain protocol aimed at reliability and re-
producibility of results (17). The major challenges for ac-
ceptance these methods by medical community are (18):
1. Standardization and quantification of clinical data,
2. Better understanding of the pathophysiological na-
ture of thermal signatures,
3. Training in both image acquisition and interpreta-
tion.
Ignoring any of the principles worked out leaves ther-
mography open to error and thus reduces acceptance of
this technique in medical diagnostic.
PATIENTS AND METHODS
Patients
The study was conducted from September 2010 to
May 2011 at University Hospital for Tumors and at Uni-
versity Hospital Centre »Sestre milosrdnice« in Zagreb,
Croatia. The seventy four female patients with histo-
pathologically confirmed breast cancer were included in
the study. In all the patients breast cancer was diagnosed
using standard protocol which have included clinical ex-
amination, mammography, ultrasound and for selected
patients MRI and/or fine needle aspiration (FNA). Ther-
mographic imaging was conducted 1 to 14 days before
scheduled surgical procedures. Patients with previous
breast surgeries, bilateral carcinomas and patients whose
histopathologically findings included cancer and some
of the benign lesions (fibroadenoma, phyllodes tumor,
and atypical hyperplasia) were excluded from the study.
The study was approved by the Ethics committee of
the University Hospital for Tumors at University Hospi-
tal Centre »Sestre milosrdnice« in Zagreb, and all partici-
pants have signed informed consent.
Thermographic system
Thermographic imaging was performed using a new
generation of digital infrared camera – Thermo Tracer
TH7102WL (NEC Sanei Instruments, Ltd., Japan). This
thermovision camera contains an uncooled focal plane
array detector (micro bolometer) with geometric resolu-
tion of 76.800 pixels per picture (320´240). Spectral ran-
ge is from 8 µm to 14 µm and the temperature range lies
between – 40°C and 120°C (optional 500°C). The mini-
mum detectable temperature resolution (difference) is
0.07° C at 30°C (Normal mode) and spatial resolution is
0.48 mm at measuring distance of 30 cm (IFOV 1.58
mrad). For remote control and transfer of data from in-
frared camera TH7102WL to a computer, we used the
previously developed an open source thermoscan analy-
ses software Thermo WEB (Thermo MED version) (19).
This software supports thermal analysis and image pre-
sentation in numerical and graphical forms of tempera-
ture values of any part of surface inside the thermogra-
phic scan.
Patient preparation and imaging
The room temperature was stable at approximately
22°C. Patients were asked to remove their clothes from
their waist upwards and were left to equilibrate with am-
bient conditions for 10–15 min. The thermographic im-
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aging was carried out by having the patient sit at a 0.9 m
distance from the camera.
According to standardized image acquisition protocol
(15), the patients raised their arms above the head and 5
images were taken: front, right and left semi- oblique,
right and left oblique, in order to obtain images of com-
plete breast skin area.
Data analysis
In order to assure consistency in the reporting of the
thermal images all pictures were analyzed by the trained
radiologists. Thermal features are divided into signs and
analyzed based on our modification of four established
protocols for characterization of breast disease (Mar-
seille, Villa Marie, Hobins, Hoekstra).
In all instances the contra lateral breast was used for
comparison.
Established protocols for thermographic character-
ization of breast disease include:
Ville Marie Infrared (IR) Grading Scale is most used
and recommended protocol in today’s everyday clinical
practice. Thermographic image findings have been di-
vided into five categories (15):
• IR1 – absence of any vascular pattern to mild vascu-
lar symmetry
• IR2 – significant but symmetrical vascular pattern
to moderate vascular asymmetry
• IR3 – one abnormal sign
• IR4 – two abnormal signs
• IR 5 – three or more abnormal signs
Marseille protocol, which was developed at the Pas-
teur Institute in Paris, recognizes also five categories:
• TH1: No abnormal features
• TH2: Some unusual metabolic activity is present,
but probably due to causes such as hormonal im-
balance
• TH3: Abnormalities are present in metabolic func-
tion, but the results are inconclusive
• TH 4: Abnormalities are found which are possibly
cancerous, but it's too soon to diagnose with cer-
tainty (approximately 38% of TH 4 patients de-
velop cancer within five years)
• TH5: Metabolic abnormalities suggest a very high
probability (about 96%) of cancer
Hoekstra thermography signs: asymmetric and hy-
perthermic vascular patterns, focal patterns with +2, 5°C
differential, asymmetric and atypical complexity of a vas-
cular pattern, asymmetric and diffuse hyperthermia (+2°C
differential) patterns involving the periareolar area or en-
tire breast, localized heat along an abnormal physical
contour (edge sign), lack of an adaptive response to an
autonomic challenge procedure (8).
Thermography criteria (Hoekstra): anarchic or com-
plex vascular features, hyperthermic focal patterns grea-
ter than 3°C differential, asymmetric and abnormal com-
plexity of a vascular pattern, asymmetric and abnormal
physical contour of more than one quadrant of a breast,
and any combination of these thermography signs.
Hobins pathological thermographic signs (two cate-
gories):
Major factors (hot spot, global heat, heat in area of
finding, nipplar heat, periareolar heat, star vascular anar-
chy, edge and bulge sign) and secondary factors (inverted
V vascular pattern, fragmented vascular anarchy, closed
vascular anarchy, vascular completeness, inferior vascu-
lar pattern, hot spot, bifurcated vascular peduncles, poin-
ted vascular peduncles, Moa-moa sign and transverse
vascular) (12).
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Figure 1(a and b). Quantitative thermographic signs heat in area of finding: A: Black arrow points to encircled area of raised thermal activity  1 ° C
in upper medial quadrant of right breast; B: Red arrow points to the same lesion of the right breast detected by MRI.
Our modified protocol that includes quantitative (A)
and descriptive (B) pathological thermographic findings
has two groups with overall eight pathological thermo-
graphic signs:
A. QUANTITATIVE THERMOGRAPHIC SIGNS:
One breast only:
1. heat in the area of finding – thermal activity  1°C on
any area of the breast that has been previously de-
picted as suspicious (clinical examination, US, mam-
mography, MRI) (Figure 1.)
2. delta 3 sign- thermal activity  3°C compared to the
surrounding breast tissue (Figure 2.)
Comparison of breasts:
1. global heat – thermal activity of one breast  1, 5 °C
compared to the healthy breast (Figure 3.)
2. periareolar heat- thermal activity of the area around
the nipple  1, 5, °C compared to the same area of
healthy breast (Figure 4.)
3. nipplar heat- thermal activity of the nipple  1°C
compared to the nipple of the healthy breast (Fig-
ure 5.)
4. hot spot sign – thermal activity of the any spot on the
breast  2 °C compared to the same spot on the
healthy breast (Figure 6.)
B. DESCRIPTIVE THERMOGRAPHIC SIGNS:
1. vascular signs – thermographic imaging of pathologi-
cal vascular signs (Figure 7.)
2. contour sign- thermographically visible changes at
the external shape of the breast (Figure 8.)
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Figure 2. Quantitative thermographic signs delta 3 sign: black arrow
points to encircled area of raised thermal activity more than 3°C
compared to the surrounding breast tissue in the outer upper quad-
rant of the left breast.
Figure 3. Quantitative thermographic signs global heat: encircled
thermal activity of right breast which is more than 1. 5° C higher
than another (healthy left) breast.
Figure 4. Quantitative thermographic signs periareolar heat: encir-
cled areas show thermal activity of the surface around the right nipple
which is more than 1. 5 ° C higher than around left periareolar area.
Figure 5. Quantitative thermographic signs nipplear heat: encircled
areas show higher thermal activity of the right nipple for more then
1°C compared to the nipple of left breast.
Figure 6. Quantitative thermographic signs hot spot sign: encircled
area shows higher thermal activity of the left breast (border of the up-
per quadrants) for more then 2°C compared to the same spot on the
healthy right breast.
RESULTS
The study included 74 female patients with a mean
age of 63.8±12.2 (range=33 to 86) years, who were oper-
ated on breast cancer. The majority of malignances were
invasive carcinoma, as shown in Table 1. (72).
Number of pathological thermographic
signs and tumor size
According to Ville Marie infrared grading scale (IR)
patients have been categorized into three groups: 7 pa-
tients with one pathological thermographic sign (IR3),
21 patients with two pathological thermographic sign
(IR4) and 46 patients with three or more pathological
thermographic signs (IR5).
Mean tumor size at pathohistologic evaluation was
21.7±13.2 (range = 2 to 58) mm. (Figure 9).
As seen in Figure 9. mean tumor size increased with
number of pathological thermographic signs, with low-
est size in IR 3 group and highest in IR 5 group.
Frequency and nature of pathological
thermographic signs
Thermographic image sample for all three groups are
shown at Figure 10 to 12.
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Figure 7. Descriptive thermographic signs vascular signs: pathologic
vessel sign on the left breast (rectangle).
Figure 8. Descriptive thermographic signs contour sign: encircled
area shows thermograpicaly visible changes at the shape (border of
lower quadrants) of the right breast.
TABLE 1
Pathologic findings of operated lesions (n = 74).
Pathohistologic diagnosis n=74
Invasive ductal carcinoma 68
Invasive lobular carcinoma 2
Invasive papillary carcinoma 1
Invasive medullary carcinoma 1
























Figure 9. Mean tumor size according to the IR group (Ville Marie
protocol).
Figure 10. IR 3 group (according to ville marie protocol) one patho-
logic thermographic sign: arrows point to pathologic vessel signs on
the right breast.
Figure 11. IR 4 group (according to ville marie protocol) two patho-
logic thermographic signs: global heat (encircled area) and heat in
area of finding (arrow) on the right breast.
Total number of registered pathological thermogra-
phic signs was 262.
Mean number of pathological thermographic signs
per patient was 3.5±1, 72 (range = 1 to 8). The most fre-
quently noted singular signs were heat in area of finding
(60) and vascular signs (54) (Figure 13).
DISCUSSION AND CONCLUSION
The results of this descriptive study clearly show that
the method of IR thermography is capable to delineate
malignant breast lesions. Furthermore, the size of de-
tected lesion correlated with the number of thermogra-
phic signs indicating the existence of breast pathology.
Hence, the authors’ interpretation of thermographic fin-
dings was based on combination of temperature and
»morphological and descriptive« signs and previously
published protocols for interpretation of pathologic IR
images of the breast (8, 12).
In our study, the most frequently noted pathological
thermographic sign was heat in area of finding that offers
a possibility to decrease the number of biopsies and FNA
in areas that do not show temperature disturbances. Ho-
wever, this observation should be evaluated in future
controlled studies. Another frequently seen pathologic
thermographic sign was combination of various vascular
signs. The thermographic visualization of »blood ves-
sels« in thermograms is a consequence of a need for
abundant supply of nutrients to maintain the tumor
growth. Nitric oxide (NO) is produced by tumor cells in
order to increase circulation, keeping the existing blood
vessels open, recruiting dormant vessels and creating
new ones (neoangiogenesis) (20).
In spite of the existence of established diagnostic pro-
tocols for thermography of breast disease, these protocols
do not inevitably offer the ideal tool to meet the chal-
lenges of IR (infra red) images interpretation. In many
situations ordinal and/or nominal scales have been used
in different published studies with equivocal results.
Furthermore, some studies still use different combina-
tions or modifications of current interpretation proto-
cols, including the unsuccessful attempt of interpretative
model based on simply visual color interpretation (10).
Some studies (7, 8, 9, 10, 13, 14, 21, 22) use interpreta-
tive models that try to improve existing protocol and
their interpretation with innovations in different soft-
ware solutions and attempt to integrate artificial neural
networking. Results and experiences of different authors
with the use of thermographic technology in the diagno-
sis of breast disease are very difficult to compare (7, 9, 10,
13, 14, 21, 22) because the initial objectives of these stud-
ies were entirely different.
To illustrate this observation, three thermographic
studies, conducted preoperatively on patients with breast
cancer deserve our attention.
On a sample of 875 biopsies Parisky (7) highlighted
the high sensitivity of the method of 97% and specificity
of 14%, while in a sample of 92 patients Arora (9) re-
ported sensitivity of 97% and specificity of 44%. In con-
trast, a study carried out by Kontos (10) noted on a sam-
ple of 63 patients a low IR method sensitivity of 25%, and
a significantly higher specificity of 85%.
Given such highly contradictory results in regard to
interpretation of IR imaging in breast cancer there is a
constant need for improvement in the field.
In our study, based on preoperative imaging of wo-
man with histopathologically confirmed breast cancer,
we have established simplified and grouped criteria for
interpretation of thermography findings.
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TABLE 2
Number and percentage of pathological thermographic
signs.
Type of pathological thermographic sign n=262
Quantitative PTS (heat in area of finding, delta
3 sign, global heat, periareolar heat, nipple heat,
hot spot sign)
195 (74%)
Descriptive PTS (vascular signs, contour signs) 67 (26%)
Figure 12. IR 5 group (according to ville marie protocol) three or
more pathologic thermographic signs: right breast: global heat, pe-
riareolar and nipplar heat (encircled areas), hot spot signs (arrows)
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Figure 13. Distribution of pathologic thermographic signs.
The authors’ proposal for thermographic evaluation
of breast disease designs the interpretation of IR images
in three steps:
1. Interpretation of quantitative thermographic signs on
each breast, separately
2. Comparison of observed quantitative signs between
the breasts
3. Recognition of descriptive and vascular signs by char-
acteristics and number in both breasts.
Finally, the thermogram should be denoted as patho-
logic if one ore more pathologic signs are identified (cate-
gories IR 3 to IR 5, according to Ville Marie protocol).
Our study clearly demonstrates that:
1. all of the surgically treated patients have had positive
thermography findings.
2. the number of thermographical pathological signs va-
ries between 1 and 8 (average 3.5 signs) per patient.
3. there is a clear correlation between the size of the tu-
mor and number of thermographical pathological signs
(IR3 group mean tumor size 11, 2 mm, IR4 group
mean tumor size 13, 7 mm, and IR 5 group 26, 5 mm /
IR 3 vs. IR 4 = NS, IR 3 and IR 4 vs. IR 5, p<0.05)
4. the most common pathological thermographical sign
is heat in the area of the finding, which means that the
site was detected as pathological by clinical methods
(mammography, US, MRI or Fine Needle Aspiration
(FNA)).
5. appearance of high percentages (20 % 54/262) of pa-
thological thermographical vascular signs indicates
possible visualization of angiogenesis in development
of neoplastic process
6. although thermographical method itself is not mor-
phological method, high percentage of appearance of
heat in the area of finding offers a possibility to de-
crease the number of biopsies and FNA in areas that
do not show temperature disturbances. However, this
observation should be evaluated in future controlled
studies.
Establishing standardized diagnostic-interpretative pro-
tocol for mammography findings (BI RADS) (23) has
enabled simpler and faster interpretation of the findings
and worldwide comparison of the results. Standardized
diagnostic- interpretative protocol for mammography hel-
ped setting the mammography as a standard method in
clinical practice as well as in screening programs. Hence,
considering current protocols and interpretative models
we have tried to contribute to standardization of ther-
mography findings interpretation by grouping and sim-
plifying current criteria.
Unfortunate, many clinicians still hesitate to consider
infrared imaging as a useful tool in spite of the steady im-
provements in both infrared technology and image anal-
ysis. The reason for this observation could be the fact that
most clinicians are unfamiliar with the physical and bio-
logical basis of infrared imaging.
Conclusively, thermography of the 21st century repre-
sents a noninvasive and biologically safe diagnostic me-
thod that has a significant clinical potential for early
breast cancer detection: it detects early lesions, the me-
thod is available to all age groups of the population, it is
inexpensive and reproducible and it is characterized by
high sensitivity and high negative predictive values (7, 18).
However, we should keep in mind the learning curve
of medical teams involved and ethical aspects as well. As
we have seen in the past (17), the introduction in clinical
use of every new diagnostic method must be in tune with
the ethical and scientific principles of medicine and heal-
thcare, including the right of the patients to be involved
in the process of diagnosis and therapy of the disease.
According to the results of this study and previously
published data in the literature, we firmly believe that a
widely adopted standard and simplified protocol for di-
agnosis of breast lesions by thermography will facilitate
introduction of this promising diagnostic tool in every
day clinical practice and screening programs, as well.
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